Skip to main content
SpringerLink
Log in

Radiotherapy cost effective in localised prostate cancer?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. National Health Service

  2. National Institute for Health and Care Excellence

Reference

  • Noble SM, et al. The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. British Journal of Cancer : 16 Jul 2020. Available from: URL: http://doi.org/10.1038/s41416-020-0978-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Radiotherapy cost effective in localised prostate cancer?. PharmacoEcon Outcomes News 858, 27 (2020). https://doi.org/10.1007/s40274-020-7000-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7000-5

Search

Navigation